The US Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Limited from entering the United States due to manufacturing violations.......
Problems do not seem to thin for Ranbaxy Laboratories. The US Food and Drug Administration has extended the ongoing consent decree with the company for its Paonta Sahib (Himachal) and Dewas (Madhya......
India's leading drug maker Ranbaxy has initiated a voluntary recall of 4,348 cartons of its skin infection drug Sotret (isotretinoin) in the United States. The entire lot pertains to a single batch......
"We are pleased to have resolved this legacy issue with the FDA as we begin the next chapter in Ranbaxy's history," stated Arun Sawhney, CEO & Managing Director of India's biggest drug-maker......
Drug-maker Ranbaxy Laboratories on Wednesday said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will......